The Pharmacy Times® Respiratory Syncytial Virus Resource Center is a comprehensive source for clinical news and expert insights on treating and preventing respiratory syncytial virus.
September 4th 2025
A single dose of an RSV vaccine significantly reduces hospitalization risk for older adults, offering protection for 2 seasons against severe infections.
Role of the Pharmacist in Vaccinating Against RSV
July 9th 2024Carrie Koenigsfeld, PharmD, FAPhA, shares strategies that pharmacists can use to effectively tackle vaccine hesitancy, particularly concerning newer vaccines such as the RSV vaccine, through building trust with patients to encourage informed decision-making.
Watch
RSV Vaccine Administration Timing and Errors
July 9th 2024A medical expert examines the ideal timing for administering RSV vaccines to adults over 60 or pregnant women, emphasizing the importance of proper timing for a single-dose vaccine and outlining the necessary steps to be taken if a pregnant woman inadvertently receives an adjuvanted RSV vaccine.
Watch
RSV Vaccine Efficacy in Pregnancy
July 2nd 2024Carrie Koenigsfeld, PharmD, FAPhA, highlights the main findings from the MATISSE trial, which evaluated the safety and efficacy of a non-adjuvanted RSV vaccine administered to pregnant women, presenting data that suggests the vaccine's effectiveness in preventing severe RSV in infants and discussing the observed adverse events in both mothers and infants.
Watch
Non-adjuvant RSV Vaccine in Older Adults
June 25th 2024An RSV medical expert provides an overview of the RENOIR trial, which investigated the efficacy and safety of an adjuvanted RSV vaccine in adults aged 60 years and older, focusing on the vaccine's effectiveness in preventing RSV-associated lower respiratory tract infections and presenting other crucial findings from the study.
Watch
Adjuvant RSV Vaccine in Older Adults
June 25th 2024Carrie Koenigsfeld, PharmD, FAPhA, reviews the pivotal findings from the AReSVi-006 trial that supported the approval of the adjuvanted RSV vaccine, including its efficacy in preventing lower respiratory tract RSV, associated adverse events, and important study limitations that may have influenced the results.
Watch
CDC Evaluates Concerns of Guillain-Barré Syndrome Following RSV Vaccination
June 17th 2024Data show that among individuals 60 years and older, the estimated rate of Guillain-Barré syndrome (GBS) after receiving an RSV vaccine was 5.0 and 1.5 per million doses of Abrysvo and Arexvy, respectively.
Read More
FDA Grants Emergency Use Authorization for 4-in-1 Respiratory Diagnostic Test
June 11th 2024The 4-in-1 respiratory diagnostic test is either a single nasopharyngeal or anterior nasal swab that can confirm or rule out SARS-CoV-2, influenza A virus, influenza B virus, and respiratory syncytial virus with a single test.
Read More
Key Considerations for Pharmacists Administering RSV Vaccines
The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.
Watch
The Pharmacist's Role in Shared Decision-Making for RSV Vaccination
Medical experts highlight the importance of clinical decision-making and the pivotal role pharmacies play in initiating conversations and identifying high-risk patients during consultations for new medications.
Watch
Challenges of Concurrent Administration: RSV and Other Vaccines
May 21st 2024The panelists address the challenges of administering multiple vaccines to eligible patients, while also discussing the timing and compatibility of administering certain vaccines simultaneously. They emphasize the importance of being receptive to patient concerns and providing guidance on childhood vaccinations for hesitant individuals.
Watch
Raising RSV Awareness Among High-Risk Patient Populations
May 21st 2024Lauren Angelo, PharmD, MBA, acknowledges the progress made in RSV vaccinations but emphasizes the persistent need to educate at-risk patients about the advantages of vaccination, citing data indicating that many patients are willing to get vaccinated but may require encouragement, and concurs that the lack of physician referral remains a crucial barrier to improving vaccination rates among high-risk groups.
Watch
Impact of Social Determinants of Health on Respiratory Syncytial Virus (RSV)
May 14th 2024Medical professionals explore social determinants of health, including access to and quality of health care, information sources, community context, and built environment, while also examining the influence of race, ethnicity, language on these factors.
Watch
Addressing Respiratory Vaccine Fatigue
May 14th 2024The panelists define vaccine fatigue and identify its primary causes as confusing messaging and the high number of annual vaccinations suggested, emphasizing that the most effective way to combat this fatigue is by tailoring the vaccine information and recommendations to the individual patient's specific needs.
Watch